Topoisomerase IV catalysis and the mechanism of quinolone action

被引:62
|
作者
Anderson, VE
Gootz, TD
Osheroff, N
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Med Oncol, Nashville, TN 37232 USA
[3] Pfizer Inc, Pfizer Cent Res, Dept Canc Immunol & Infect Dis, Groton, CT 06340 USA
关键词
D O I
10.1074/jbc.273.28.17879
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Topoisomerase IV is.bacterial type II topoisomerase that is essential for proper chromosome segregation and is a target for quinolone-based antimicrobial agents. Despite the importance of this enzyme to the survival of prokaryotic cells and to the treatment of bacterial infections, relatively little is known about the details of its catalytic mechanism or the basis by which quinolones alter its enzymatic functions. Therefore, a series of experiments that analyzed individual steps of the topoisomerase IV catalytic cycle were undertaken to address these critical mechanistic issues. The following conclusions were drawn, First, equilibrium levels of DNA cleavage mediated by the bacterial enzyme were considerably (>10-fold) higher than those observed with its eukaryotic counterparts. To a large extent, this reflected decreased rates of DNA religation. Second, the preference of topoisomerase TV for catalyzing DNA decatenation over relaxation reflects increased rates of strand passage and enzyme recycling rather than a heightened recognition of intermolecular DNA helices, Third, quinolones stimulate topoisomerase IV-mediated DNA cleavage both by increasing rates of DNA scission and by inhibiting religation of cleaved DNA. Finally, quinolones inhibit the overall catalytic activity of topoisomerase TV primarily by interfering with enzyme-ATP interactions.
引用
收藏
页码:17879 / 17885
页数:7
相关论文
共 50 条
  • [31] Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro
    Bébéar, CM
    Renaudin, H
    Charron, A
    Bové, JM
    Bébéar, C
    Renaudin, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2304 - 2311
  • [32] Novel, non-quinolone inhibitors of DNA gyrase and topoisomerase IV: Antibacterial activity and resistance mechanisms
    Mitton-Fry, Mark
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [33] Proton relay mechanism of general acid catalysis by DNA topoisomerase IB
    Krogh, BO
    Shuman, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) : 5711 - 5714
  • [34] MatP regulates the coordinated action of topoisomerase IV and MukBEF in chromosome segregation
    Sophie Nolivos
    Amy L. Upton
    Anjana Badrinarayanan
    Julius Müller
    Katarzyna Zawadzka
    Jakub Wiktor
    Amber Gill
    Lidia Arciszewska
    Emilien Nicolas
    David Sherratt
    Nature Communications, 7
  • [35] MatP regulates the coordinated action of topoisomerase IV and MukBEF in chromosome segregation
    Nolivos, Sophie
    Upton, Amy L.
    Badrinarayanan, Anjana
    Mueller, Julius
    Zawadzka, Katarzyna
    Wiktor, Jakub
    Gill, Amber
    Arciszewska, Lidia
    Nicolas, Emilien
    Sherratt, David
    NATURE COMMUNICATIONS, 2016, 7
  • [36] Identification of amino acid residues that determine the stability and the cyototoxicity of topoisomerase IV-quinolone-DNA ternary complexes
    Pfeiffer, ES
    Hiasa, H
    FASEB JOURNAL, 2004, 18 (05): : A997 - A997
  • [37] Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV
    Breines, DM
    Ouabdesselam, S
    Ng, EY
    Tankovic, J
    Shah, S
    Soussy, CJ
    Hooper, DC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) : 175 - 179
  • [38] Characterization of mutations in DNA gyrase and topoisomerase IV involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro
    Reinhardt, AK
    Bébéar, CM
    Kobisch, M
    Kempf, I
    Gautier-Bouchardon, AV
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) : 590 - 593
  • [39] Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
    Burden, DA
    Osheroff, N
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3): : 139 - 154
  • [40] DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae
    Pan, XS
    Fisher, LM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 2810 - 2816